Ethics & utility of controlled human infection studies (CHIS) in low- & middle-income countries.
作者信息
Eberts Jake Daniel, Eyal Nir, Banerjee Sayantan
机构信息
Department of Communications, 1Day Sooner, Claymont, Delaware, United States.
Institute for Health and School of Public Health, Rutgers University, New Brunswick, New Jersey, United States.
出版信息
Indian J Med Res. 2024;160(3&4):262-266. doi: 10.25259/IJMR_985_2024.
Abstract
摘要
相似文献
1
Ethics & utility of controlled human infection studies (CHIS) in low- & middle-income countries.低收入和中等收入国家中人类感染对照研究（CHIS）的伦理与效用
Indian J Med Res. 2024;160(3&4):262-266. doi: 10.25259/IJMR_985_2024.
2
Ethical issues surrounding controlled human infection challenge studies in endemic low-and middle-income countries.伦理问题围绕着在流行的低和中等收入国家进行的受控人体感染挑战研究。
Bioethics. 2020 Oct;34(8):797-808. doi: 10.1111/bioe.12802. Epub 2020 Aug 30.
3
Virtue ethics and the unsettled ethical questions in controlled human infection studies.美德伦理与人为控制感染研究中悬而未决的伦理问题。
Bioethics. 2024 Oct;38(8):692-701. doi: 10.1111/bioe.13326. Epub 2024 Jun 17.
4
Perceptions of members of ethics committees of medical institutions in India on controlled human infection studies (CHIS) following a sensitization workshop: a systematic survey.在一次宣传研讨会后，印度医疗机构伦理委员会成员对人体感染对照研究（CHIS）的看法：一项系统调查。
Monash Bioeth Rev. 2025 Feb 13. doi: 10.1007/s40592-025-00231-8.
5
Informed consent for controlled human infection studies in low- and middle-income countries: Ethical challenges and proposed solutions.在中低收入国家进行人体受控感染研究的知情同意：伦理挑战与解决方案建议。
Bioethics. 2020 Oct;34(8):809-818. doi: 10.1111/bioe.12795. Epub 2020 Aug 10.
6
Reexamining the categorical exclusion of pediatric participants from controlled human infection trials.重新审视将儿科参与者排除在人体感染控制试验之外的分类排除。
Bioethics. 2020 Oct;34(8):785-796. doi: 10.1111/bioe.12788. Epub 2020 Jul 26.
7
Lessons and Implementation Challenges of Community Health Information System in LMICs: A Scoping Review of Literature.低收入和中等收入国家社区卫生信息系统的经验教训与实施挑战：文献综述
Online J Public Health Inform. 2022 Nov 7;14(1):e5. doi: 10.5210/ojphi.v14i1.12731. eCollection 2022.
8
An analysis of controlled human infection studies registered on ClinicalTrials.gov.对在ClinicalTrials.gov上注册的人体对照感染研究的分析。
BMJ Open. 2025 Feb 7;15(2):e085250. doi: 10.1136/bmjopen-2024-085250.
9
Focus on vulnerable populations and promoting equity in health service utilization--an analysis of visitor characteristics and service utilization of the Chinese community health service.关注弱势群体并促进卫生服务利用的公平性——中国社区卫生服务就诊者特征与服务利用分析
BMC Public Health. 2014 May 26;14:503. doi: 10.1186/1471-2458-14-503.
10
SARS-CoV-2 challenge studies: ethics and risk minimisation.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）挑战研究：伦理与风险最小化
J Med Ethics. 2020 Sep 25;47(12):e79. doi: 10.1136/medethics-2020-106504.
本文引用的文献
1
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023.第四次人工感染控制模型（CHIM）会议，CHIM 监管问题，2023 年 5 月 24 日。
Biologicals. 2024 Feb;85:101745. doi: 10.1016/j.biologicals.2024.101745. Epub 2024 Feb 10.
2
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy.人类挑战试验在疫苗研发中的战略和科学贡献：事实与幻想。
Lancet Infect Dis. 2023 Dec;23(12):e533-e546. doi: 10.1016/S1473-3099(23)00294-3. Epub 2023 Aug 10.
3
Perceptions about controlled human infection model (CHIM) studies among members of ethics committees of Indian medical institutions: A qualitative exploration.印度医疗机构伦理委员会成员对人体感染控制模型（CHIM）研究的看法：一项定性探索。
Wellcome Open Res. 2023 Feb 28;7:209. doi: 10.12688/wellcomeopenres.17968.2. eCollection 2022.
4
A Systematic Review of Human Challenge Trials, Designs, and Safety.人类挑战试验的系统评价、设计和安全性。
Clin Infect Dis. 2023 Feb 18;76(4):609-619. doi: 10.1093/cid/ciac820.
5
Controlled Human Infection Models To Accelerate Vaccine Development.控制人体感染模型以加速疫苗开发。
Clin Microbiol Rev. 2022 Sep 21;35(3):e0000821. doi: 10.1128/cmr.00008-21. Epub 2022 Jul 6.
6
Ethical considerations around volunteer payments in a malaria human infection study in Kenya: an embedded empirical ethics study.肯尼亚疟疾人体感染研究中志愿者报酬的伦理考虑：一项嵌入式经验伦理研究。
BMC Med Ethics. 2022 Apr 20;23(1):46. doi: 10.1186/s12910-022-00783-y.
7
"At first, I was very afraid"-a qualitative description of participants' views and experiences in the first Human Infection Study in Malawi.“起初，我非常害怕”——对马拉维首次人类感染研究中参与者观点和经历的定性描述。
Wellcome Open Res. 2021 Oct 4;6:89. doi: 10.12688/wellcomeopenres.16587.2. eCollection 2021.
8
Understanding the benefits and burdens associated with a malaria human infection study in Kenya: experiences of study volunteers and other stakeholders.了解肯尼亚一项疟疾人体感染研究的益处与负担：研究志愿者及其他利益相关者的经历
Trials. 2021 Jul 26;22(1):494. doi: 10.1186/s13063-021-05455-7.
9
Human challenge trials in vaccine development.疫苗研发中的人体挑战试验。
Semin Immunol. 2020 Aug;50:101429. doi: 10.1016/j.smim.2020.101429. Epub 2020 Nov 29.
10
Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials.以金钱为导向的冒险者或深思熟虑的决策者：一项关于人体受控感染试验参与者的横断面调查研究。
BMJ Open. 2020 Jul 26;10(7):e033796. doi: 10.1136/bmjopen-2019-033796.
Zotero 插件